New Findings from National Cancer Institute (NCI) Describe Advances in Colon Cancer (Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer)

  • William Figg

Press/Media

Period1 Mar 2023

Media coverage

1

Media coverage

  • TitleNew Findings from National Cancer Institute (NCI) Describe Advances in Colon Cancer (Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date1/03/23
    PersonsWilliam Figg
View all 1
View less

Related content